Get started
TIGER NASDAQ BIOTIGER NASDAQ BIOTIGER NASDAQ BIO

TIGER NASDAQ BIO

No trades
See on Supercharts
Overview
Analysis
Holdings Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪52.01 B‬ KRW
Fund flows (1Y)
‪8.99 B‬ KRW
Dividend yield (indicated)
0.05%
Discount/Premium to NAV
—
Shares outstanding
‪2.54 M‬
Expense ratio
0.30%

About TIGER NASDAQ BIO


Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Tiger ETF
Home page
tigeretf.com
Inception date
Aug 26, 2014
Index tracked
NASDAQ Biotechnology Index
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Income tax type
Capital Gains
Primary advisor
Mirae Asset Global Investments Co., Ltd.
ISIN
KR7203780002
The TIGER NASDAQ BIO ETF seeks investment results that corresponds generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index (KRW).

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Exchange-specific
Geography
U.S.
Weighting scheme
Market cap
Selection criteria
NASDAQ - listed

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of May 15, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.00%
Health Technology95.89%
Technology Services1.25%
Commercial Services1.20%
Health Services0.63%
Process Industries0.02%
Bonds, Cash & Other1.00%
Cash1.00%
Stock breakdown by region
0%83%15%0.4%
North America83.78%
Europe15.80%
Asia0.37%
Oceania0.05%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows